In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Antares Pharma, Inc.

http://www.antarespharma.com/

Latest From Antares Pharma, Inc.

Takeda’s Maribavir For Post-Transplant Cytomegalovirus Might See Split Panel Vote

First-in-class CMV treatment showed better efficacy in refractory patients with genetic resistance than those without; US FDA advisory committee will separately consider benefit-risk in each type of patient. On the safety side, taste disturbance is the only adverse event that stands out.

Advisory Committees Drug Review

Amgen’s Bevacizumab Biosimilar Is Alone On Australia’s PBS

US-based giant Amgen has seen its Mvasi biosimilar become the sole bevacizumab product listed on Australia’s Pharmaceutical Benefits Scheme.

Biosimilars Generic Drugs

China Re-Infection Case Ignites Antibody Durability Debate

Amid a case of re-infection of a vaccinated healthcare worker in western China’s Xi’an city, and ongoing debate over domestic vaccines' efficacy, increasing attention is being paid in China to raising inoculation rates for COVID-19 and moving towards herd immunity.

China Coronavirus COVID-19

New China COVID Vaccine Arriving But COVAX Pledge May Need A Booster

China’s first domestically-developed recombinant protein vaccine for COVID-19 moves forward in late-stage trials in two countries.

Coronavirus COVID-19 Vaccines
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Topical Delivery
      • Transdermal
  • Other Names / Subsidiaries
    • Medi-Ject Corporation
    • Permatec
UsernamePublicRestriction

Register